nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolasetron—CYP2C9—Fenofibrate—coronary artery disease	0.0486	0.0727	CbGbCtD
Dolasetron—CYP2C9—Gemfibrozil—coronary artery disease	0.0389	0.0582	CbGbCtD
Dolasetron—CYP2C9—Clopidogrel—coronary artery disease	0.0337	0.0504	CbGbCtD
Dolasetron—CYP3A4—Ticagrelor—coronary artery disease	0.0317	0.0475	CbGbCtD
Dolasetron—CYP2C9—Pitavastatin—coronary artery disease	0.0295	0.0441	CbGbCtD
Dolasetron—CYP2C9—Valsartan—coronary artery disease	0.0287	0.0429	CbGbCtD
Dolasetron—CYP3A4—Fenofibrate—coronary artery disease	0.0283	0.0423	CbGbCtD
Dolasetron—CYP2D6—Niacin—coronary artery disease	0.0234	0.0349	CbGbCtD
Dolasetron—CYP3A4—Gemfibrozil—coronary artery disease	0.0226	0.0338	CbGbCtD
Dolasetron—CYP2C9—Rosuvastatin—coronary artery disease	0.0217	0.0325	CbGbCtD
Dolasetron—CYP2D6—Timolol—coronary artery disease	0.0217	0.0325	CbGbCtD
Dolasetron—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.0212	0.0317	CbGbCtD
Dolasetron—CYP2C9—Simvastatin—coronary artery disease	0.0202	0.0302	CbGbCtD
Dolasetron—CYP2C9—Pravastatin—coronary artery disease	0.0198	0.0296	CbGbCtD
Dolasetron—CYP2C9—Lovastatin—coronary artery disease	0.0198	0.0296	CbGbCtD
Dolasetron—CYP3A4—Clopidogrel—coronary artery disease	0.0196	0.0293	CbGbCtD
Dolasetron—CYP2D6—Captopril—coronary artery disease	0.0191	0.0286	CbGbCtD
Dolasetron—CYP2D6—Simvastatin—coronary artery disease	0.0185	0.0276	CbGbCtD
Dolasetron—CYP3A4—Eplerenone—coronary artery disease	0.0182	0.0273	CbGbCtD
Dolasetron—CYP2D6—Lovastatin—coronary artery disease	0.0181	0.027	CbGbCtD
Dolasetron—CYP2D6—Pravastatin—coronary artery disease	0.0181	0.027	CbGbCtD
Dolasetron—CYP2C9—Atorvastatin—coronary artery disease	0.018	0.0269	CbGbCtD
Dolasetron—CYP2C9—Losartan—coronary artery disease	0.0165	0.0246	CbGbCtD
Dolasetron—CYP2D6—Atorvastatin—coronary artery disease	0.0165	0.0246	CbGbCtD
Dolasetron—CYP3A4—Enalapril—coronary artery disease	0.0162	0.0243	CbGbCtD
Dolasetron—CYP3A4—Rosuvastatin—coronary artery disease	0.0126	0.0189	CbGbCtD
Dolasetron—CYP3A4—Ezetimibe—coronary artery disease	0.0126	0.0189	CbGbCtD
Dolasetron—CYP3A4—Simvastatin—coronary artery disease	0.0117	0.0176	CbGbCtD
Dolasetron—CYP3A4—Lovastatin—coronary artery disease	0.0115	0.0172	CbGbCtD
Dolasetron—CYP3A4—Pravastatin—coronary artery disease	0.0115	0.0172	CbGbCtD
Dolasetron—CYP3A4—Atorvastatin—coronary artery disease	0.0105	0.0157	CbGbCtD
Dolasetron—CYP2C9—cardial valve—coronary artery disease	0.00984	0.482	CbGeAlD
Dolasetron—CYP3A4—Losartan—coronary artery disease	0.00957	0.0143	CbGbCtD
Dolasetron—HTR3A—vagus nerve—coronary artery disease	0.00766	0.375	CbGeAlD
Dolasetron—HTR3A—blood—coronary artery disease	0.000829	0.0406	CbGeAlD
Dolasetron—CYP2C9—heart—coronary artery disease	0.000544	0.0267	CbGeAlD
Dolasetron—CYP2C9—cardiovascular system—coronary artery disease	0.000513	0.0252	CbGeAlD
Dolasetron—CYP2C9—blood—coronary artery disease	0.000406	0.0199	CbGeAlD
Dolasetron—CYP3A4—blood—coronary artery disease	0.00031	0.0152	CbGeAlD
Dolasetron—CYP2D6—blood—coronary artery disease	0.000305	0.0149	CbGeAlD
Dolasetron—Cough—Timolol—coronary artery disease	0.000106	0.000384	CcSEcCtD
Dolasetron—Diarrhoea—Simvastatin—coronary artery disease	0.000106	0.000384	CcSEcCtD
Dolasetron—Chest pain—Ramipril—coronary artery disease	0.000106	0.000383	CcSEcCtD
Dolasetron—Myalgia—Ramipril—coronary artery disease	0.000106	0.000383	CcSEcCtD
Dolasetron—Arthralgia—Ramipril—coronary artery disease	0.000106	0.000383	CcSEcCtD
Dolasetron—Fatigue—Furosemide—coronary artery disease	0.000106	0.000383	CcSEcCtD
Dolasetron—Tremor—Lisinopril—coronary artery disease	0.000106	0.000382	CcSEcCtD
Dolasetron—Abdominal pain—Telmisartan—coronary artery disease	0.000106	0.000382	CcSEcCtD
Dolasetron—Body temperature increased—Telmisartan—coronary artery disease	0.000106	0.000382	CcSEcCtD
Dolasetron—Dyspnoea—Losartan—coronary artery disease	0.000106	0.000382	CcSEcCtD
Dolasetron—Anxiety—Ramipril—coronary artery disease	0.000105	0.000382	CcSEcCtD
Dolasetron—Somnolence—Losartan—coronary artery disease	0.000105	0.000381	CcSEcCtD
Dolasetron—Dizziness—Eplerenone—coronary artery disease	0.000105	0.000381	CcSEcCtD
Dolasetron—Rash—Clopidogrel—coronary artery disease	0.000105	0.000381	CcSEcCtD
Dolasetron—Dermatitis—Clopidogrel—coronary artery disease	0.000105	0.00038	CcSEcCtD
Dolasetron—Asthenia—Valsartan—coronary artery disease	0.000105	0.00038	CcSEcCtD
Dolasetron—Hypertension—Timolol—coronary artery disease	0.000105	0.00038	CcSEcCtD
Dolasetron—Pain—Furosemide—coronary artery disease	0.000105	0.00038	CcSEcCtD
Dolasetron—Constipation—Furosemide—coronary artery disease	0.000105	0.00038	CcSEcCtD
Dolasetron—Hypersensitivity—Niacin—coronary artery disease	0.000105	0.000379	CcSEcCtD
Dolasetron—Ill-defined disorder—Lisinopril—coronary artery disease	0.000105	0.000379	CcSEcCtD
Dolasetron—Discomfort—Ramipril—coronary artery disease	0.000105	0.000379	CcSEcCtD
Dolasetron—Asthenia—Olmesartan—coronary artery disease	0.000104	0.000378	CcSEcCtD
Dolasetron—Headache—Clopidogrel—coronary artery disease	0.000104	0.000378	CcSEcCtD
Dolasetron—Rash—Lovastatin—coronary artery disease	0.000104	0.000378	CcSEcCtD
Dolasetron—Dermatitis—Lovastatin—coronary artery disease	0.000104	0.000378	CcSEcCtD
Dolasetron—Anaemia—Lisinopril—coronary artery disease	0.000104	0.000377	CcSEcCtD
Dolasetron—Dyspepsia—Losartan—coronary artery disease	0.000104	0.000377	CcSEcCtD
Dolasetron—Feeling abnormal—Perindopril—coronary artery disease	0.000104	0.000376	CcSEcCtD
Dolasetron—Headache—Lovastatin—coronary artery disease	0.000104	0.000376	CcSEcCtD
Dolasetron—Pruritus—Valsartan—coronary artery disease	0.000104	0.000375	CcSEcCtD
Dolasetron—Dry mouth—Ramipril—coronary artery disease	0.000104	0.000375	CcSEcCtD
Dolasetron—Chest pain—Timolol—coronary artery disease	0.000103	0.000375	CcSEcCtD
Dolasetron—Arthralgia—Timolol—coronary artery disease	0.000103	0.000375	CcSEcCtD
Dolasetron—Myalgia—Timolol—coronary artery disease	0.000103	0.000375	CcSEcCtD
Dolasetron—Hypersensitivity—Pravastatin—coronary artery disease	0.000103	0.000374	CcSEcCtD
Dolasetron—Gastrointestinal pain—Perindopril—coronary artery disease	0.000103	0.000373	CcSEcCtD
Dolasetron—Anxiety—Timolol—coronary artery disease	0.000103	0.000373	CcSEcCtD
Dolasetron—Angioedema—Lisinopril—coronary artery disease	0.000103	0.000373	CcSEcCtD
Dolasetron—Pruritus—Olmesartan—coronary artery disease	0.000103	0.000373	CcSEcCtD
Dolasetron—Decreased appetite—Losartan—coronary artery disease	0.000103	0.000372	CcSEcCtD
Dolasetron—Abdominal pain—Captopril—coronary artery disease	0.000103	0.000372	CcSEcCtD
Dolasetron—Body temperature increased—Captopril—coronary artery disease	0.000103	0.000372	CcSEcCtD
Dolasetron—Dizziness—Simvastatin—coronary artery disease	0.000102	0.000371	CcSEcCtD
Dolasetron—Rash—Ezetimibe—coronary artery disease	0.000102	0.000371	CcSEcCtD
Dolasetron—Dermatitis—Ezetimibe—coronary artery disease	0.000102	0.000371	CcSEcCtD
Dolasetron—Confusional state—Ramipril—coronary artery disease	0.000102	0.00037	CcSEcCtD
Dolasetron—Discomfort—Timolol—coronary artery disease	0.000102	0.00037	CcSEcCtD
Dolasetron—Asthenia—Niacin—coronary artery disease	0.000102	0.00037	CcSEcCtD
Dolasetron—Fatigue—Losartan—coronary artery disease	0.000102	0.000369	CcSEcCtD
Dolasetron—Headache—Ezetimibe—coronary artery disease	0.000102	0.000368	CcSEcCtD
Dolasetron—Malaise—Lisinopril—coronary artery disease	0.000102	0.000368	CcSEcCtD
Dolasetron—Anaphylactic shock—Ramipril—coronary artery disease	0.000101	0.000367	CcSEcCtD
Dolasetron—Oedema—Ramipril—coronary artery disease	0.000101	0.000367	CcSEcCtD
Dolasetron—Vertigo—Lisinopril—coronary artery disease	0.000101	0.000367	CcSEcCtD
Dolasetron—Dry mouth—Timolol—coronary artery disease	0.000101	0.000366	CcSEcCtD
Dolasetron—Constipation—Losartan—coronary artery disease	0.000101	0.000366	CcSEcCtD
Dolasetron—Pain—Losartan—coronary artery disease	0.000101	0.000366	CcSEcCtD
Dolasetron—Syncope—Lisinopril—coronary artery disease	0.000101	0.000366	CcSEcCtD
Dolasetron—Feeling abnormal—Furosemide—coronary artery disease	0.000101	0.000366	CcSEcCtD
Dolasetron—Pruritus—Niacin—coronary artery disease	0.000101	0.000364	CcSEcCtD
Dolasetron—Asthenia—Pravastatin—coronary artery disease	0.000101	0.000364	CcSEcCtD
Dolasetron—Gastrointestinal pain—Furosemide—coronary artery disease	0.0001	0.000363	CcSEcCtD
Dolasetron—Rash—Eplerenone—coronary artery disease	0.0001	0.000363	CcSEcCtD
Dolasetron—Urticaria—Perindopril—coronary artery disease	0.0001	0.000363	CcSEcCtD
Dolasetron—Hypersensitivity—Trandolapril—coronary artery disease	0.0001	0.000363	CcSEcCtD
Dolasetron—Dermatitis—Eplerenone—coronary artery disease	0.0001	0.000363	CcSEcCtD
Dolasetron—Diarrhoea—Valsartan—coronary artery disease	0.0001	0.000362	CcSEcCtD
Dolasetron—Confusional state—Timolol—coronary artery disease	0.0001	0.000362	CcSEcCtD
Dolasetron—Shock—Ramipril—coronary artery disease	9.98e-05	0.000361	CcSEcCtD
Dolasetron—Hypersensitivity—Enalapril—coronary artery disease	9.98e-05	0.000361	CcSEcCtD
Dolasetron—Abdominal pain—Perindopril—coronary artery disease	9.97e-05	0.000361	CcSEcCtD
Dolasetron—Body temperature increased—Perindopril—coronary artery disease	9.97e-05	0.000361	CcSEcCtD
Dolasetron—Palpitations—Lisinopril—coronary artery disease	9.96e-05	0.000361	CcSEcCtD
Dolasetron—Diarrhoea—Olmesartan—coronary artery disease	9.96e-05	0.000361	CcSEcCtD
Dolasetron—Headache—Eplerenone—coronary artery disease	9.96e-05	0.000361	CcSEcCtD
Dolasetron—Thrombocytopenia—Ramipril—coronary artery disease	9.94e-05	0.00036	CcSEcCtD
Dolasetron—Oedema—Timolol—coronary artery disease	9.92e-05	0.000359	CcSEcCtD
Dolasetron—Anaphylactic shock—Timolol—coronary artery disease	9.92e-05	0.000359	CcSEcCtD
Dolasetron—Pruritus—Pravastatin—coronary artery disease	9.91e-05	0.000359	CcSEcCtD
Dolasetron—Loss of consciousness—Lisinopril—coronary artery disease	9.91e-05	0.000359	CcSEcCtD
Dolasetron—Tachycardia—Ramipril—coronary artery disease	9.9e-05	0.000359	CcSEcCtD
Dolasetron—Hypersensitivity—Telmisartan—coronary artery disease	9.85e-05	0.000356	CcSEcCtD
Dolasetron—Cough—Lisinopril—coronary artery disease	9.84e-05	0.000356	CcSEcCtD
Dolasetron—Hyperhidrosis—Ramipril—coronary artery disease	9.81e-05	0.000355	CcSEcCtD
Dolasetron—Rash—Simvastatin—coronary artery disease	9.77e-05	0.000354	CcSEcCtD
Dolasetron—Dermatitis—Simvastatin—coronary artery disease	9.76e-05	0.000353	CcSEcCtD
Dolasetron—Asthenia—Trandolapril—coronary artery disease	9.76e-05	0.000353	CcSEcCtD
Dolasetron—Shock—Timolol—coronary artery disease	9.76e-05	0.000353	CcSEcCtD
Dolasetron—Feeling abnormal—Losartan—coronary artery disease	9.75e-05	0.000353	CcSEcCtD
Dolasetron—Urticaria—Furosemide—coronary artery disease	9.74e-05	0.000353	CcSEcCtD
Dolasetron—Diarrhoea—Niacin—coronary artery disease	9.73e-05	0.000352	CcSEcCtD
Dolasetron—Asthenia—Enalapril—coronary artery disease	9.72e-05	0.000352	CcSEcCtD
Dolasetron—Headache—Simvastatin—coronary artery disease	9.71e-05	0.000351	CcSEcCtD
Dolasetron—Abdominal pain—Furosemide—coronary artery disease	9.7e-05	0.000351	CcSEcCtD
Dolasetron—Body temperature increased—Furosemide—coronary artery disease	9.7e-05	0.000351	CcSEcCtD
Dolasetron—Gastrointestinal pain—Losartan—coronary artery disease	9.68e-05	0.00035	CcSEcCtD
Dolasetron—Dizziness—Valsartan—coronary artery disease	9.68e-05	0.00035	CcSEcCtD
Dolasetron—Anorexia—Ramipril—coronary artery disease	9.67e-05	0.00035	CcSEcCtD
Dolasetron—Dizziness—Olmesartan—coronary artery disease	9.63e-05	0.000349	CcSEcCtD
Dolasetron—Pruritus—Trandolapril—coronary artery disease	9.62e-05	0.000348	CcSEcCtD
Dolasetron—Myalgia—Lisinopril—coronary artery disease	9.6e-05	0.000348	CcSEcCtD
Dolasetron—Chest pain—Lisinopril—coronary artery disease	9.6e-05	0.000348	CcSEcCtD
Dolasetron—Arthralgia—Lisinopril—coronary artery disease	9.6e-05	0.000348	CcSEcCtD
Dolasetron—Hyperhidrosis—Timolol—coronary artery disease	9.59e-05	0.000347	CcSEcCtD
Dolasetron—Asthenia—Telmisartan—coronary artery disease	9.59e-05	0.000347	CcSEcCtD
Dolasetron—Pruritus—Enalapril—coronary artery disease	9.59e-05	0.000347	CcSEcCtD
Dolasetron—Diarrhoea—Pravastatin—coronary artery disease	9.58e-05	0.000347	CcSEcCtD
Dolasetron—Anxiety—Lisinopril—coronary artery disease	9.57e-05	0.000346	CcSEcCtD
Dolasetron—Discomfort—Lisinopril—coronary artery disease	9.48e-05	0.000343	CcSEcCtD
Dolasetron—Hypotension—Ramipril—coronary artery disease	9.48e-05	0.000343	CcSEcCtD
Dolasetron—Anorexia—Timolol—coronary artery disease	9.46e-05	0.000342	CcSEcCtD
Dolasetron—Pruritus—Telmisartan—coronary artery disease	9.45e-05	0.000342	CcSEcCtD
Dolasetron—Dizziness—Niacin—coronary artery disease	9.41e-05	0.000341	CcSEcCtD
Dolasetron—Urticaria—Losartan—coronary artery disease	9.4e-05	0.00034	CcSEcCtD
Dolasetron—Dry mouth—Lisinopril—coronary artery disease	9.39e-05	0.00034	CcSEcCtD
Dolasetron—Body temperature increased—Losartan—coronary artery disease	9.36e-05	0.000339	CcSEcCtD
Dolasetron—Abdominal pain—Losartan—coronary artery disease	9.36e-05	0.000339	CcSEcCtD
Dolasetron—Asthenia—Captopril—coronary artery disease	9.32e-05	0.000338	CcSEcCtD
Dolasetron—Diarrhoea—Trandolapril—coronary artery disease	9.31e-05	0.000337	CcSEcCtD
Dolasetron—Confusional state—Lisinopril—coronary artery disease	9.28e-05	0.000336	CcSEcCtD
Dolasetron—Diarrhoea—Enalapril—coronary artery disease	9.27e-05	0.000336	CcSEcCtD
Dolasetron—Hypotension—Timolol—coronary artery disease	9.27e-05	0.000336	CcSEcCtD
Dolasetron—Dizziness—Pravastatin—coronary artery disease	9.26e-05	0.000335	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Ramipril—coronary artery disease	9.25e-05	0.000335	CcSEcCtD
Dolasetron—Rash—Valsartan—coronary artery disease	9.23e-05	0.000334	CcSEcCtD
Dolasetron—Dermatitis—Valsartan—coronary artery disease	9.22e-05	0.000334	CcSEcCtD
Dolasetron—Anaphylactic shock—Lisinopril—coronary artery disease	9.2e-05	0.000333	CcSEcCtD
Dolasetron—Oedema—Lisinopril—coronary artery disease	9.2e-05	0.000333	CcSEcCtD
Dolasetron—Pruritus—Captopril—coronary artery disease	9.19e-05	0.000333	CcSEcCtD
Dolasetron—Rash—Olmesartan—coronary artery disease	9.18e-05	0.000332	CcSEcCtD
Dolasetron—Dermatitis—Olmesartan—coronary artery disease	9.17e-05	0.000332	CcSEcCtD
Dolasetron—Headache—Valsartan—coronary artery disease	9.17e-05	0.000332	CcSEcCtD
Dolasetron—Diarrhoea—Telmisartan—coronary artery disease	9.14e-05	0.000331	CcSEcCtD
Dolasetron—Headache—Olmesartan—coronary artery disease	9.12e-05	0.00033	CcSEcCtD
Dolasetron—Paraesthesia—Ramipril—coronary artery disease	9.11e-05	0.00033	CcSEcCtD
Dolasetron—Shock—Lisinopril—coronary artery disease	9.05e-05	0.000328	CcSEcCtD
Dolasetron—Asthenia—Perindopril—coronary artery disease	9.05e-05	0.000328	CcSEcCtD
Dolasetron—Dyspnoea—Ramipril—coronary artery disease	9.05e-05	0.000327	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Timolol—coronary artery disease	9.04e-05	0.000327	CcSEcCtD
Dolasetron—Hypersensitivity—Furosemide—coronary artery disease	9.04e-05	0.000327	CcSEcCtD
Dolasetron—Somnolence—Ramipril—coronary artery disease	9.02e-05	0.000327	CcSEcCtD
Dolasetron—Thrombocytopenia—Lisinopril—coronary artery disease	9.01e-05	0.000326	CcSEcCtD
Dolasetron—Dizziness—Trandolapril—coronary artery disease	9e-05	0.000326	CcSEcCtD
Dolasetron—Tachycardia—Lisinopril—coronary artery disease	8.98e-05	0.000325	CcSEcCtD
Dolasetron—Rash—Niacin—coronary artery disease	8.97e-05	0.000325	CcSEcCtD
Dolasetron—Dermatitis—Niacin—coronary artery disease	8.96e-05	0.000324	CcSEcCtD
Dolasetron—Dizziness—Enalapril—coronary artery disease	8.96e-05	0.000324	CcSEcCtD
Dolasetron—Dyspepsia—Ramipril—coronary artery disease	8.93e-05	0.000323	CcSEcCtD
Dolasetron—Pruritus—Perindopril—coronary artery disease	8.93e-05	0.000323	CcSEcCtD
Dolasetron—Headache—Niacin—coronary artery disease	8.91e-05	0.000323	CcSEcCtD
Dolasetron—Paraesthesia—Timolol—coronary artery disease	8.91e-05	0.000322	CcSEcCtD
Dolasetron—Hyperhidrosis—Lisinopril—coronary artery disease	8.9e-05	0.000322	CcSEcCtD
Dolasetron—Diarrhoea—Captopril—coronary artery disease	8.89e-05	0.000322	CcSEcCtD
Dolasetron—Dyspnoea—Timolol—coronary artery disease	8.84e-05	0.00032	CcSEcCtD
Dolasetron—Dizziness—Telmisartan—coronary artery disease	8.84e-05	0.00032	CcSEcCtD
Dolasetron—Rash—Pravastatin—coronary artery disease	8.83e-05	0.00032	CcSEcCtD
Dolasetron—Dermatitis—Pravastatin—coronary artery disease	8.82e-05	0.000319	CcSEcCtD
Dolasetron—Decreased appetite—Ramipril—coronary artery disease	8.82e-05	0.000319	CcSEcCtD
Dolasetron—Somnolence—Timolol—coronary artery disease	8.82e-05	0.000319	CcSEcCtD
Dolasetron—Asthenia—Furosemide—coronary artery disease	8.8e-05	0.000319	CcSEcCtD
Dolasetron—Headache—Pravastatin—coronary artery disease	8.78e-05	0.000318	CcSEcCtD
Dolasetron—Anorexia—Lisinopril—coronary artery disease	8.77e-05	0.000318	CcSEcCtD
Dolasetron—Fatigue—Ramipril—coronary artery disease	8.75e-05	0.000317	CcSEcCtD
Dolasetron—Dyspepsia—Timolol—coronary artery disease	8.73e-05	0.000316	CcSEcCtD
Dolasetron—Hypersensitivity—Losartan—coronary artery disease	8.72e-05	0.000316	CcSEcCtD
Dolasetron—Pruritus—Furosemide—coronary artery disease	8.68e-05	0.000314	CcSEcCtD
Dolasetron—Constipation—Ramipril—coronary artery disease	8.68e-05	0.000314	CcSEcCtD
Dolasetron—Diarrhoea—Perindopril—coronary artery disease	8.63e-05	0.000313	CcSEcCtD
Dolasetron—Decreased appetite—Timolol—coronary artery disease	8.62e-05	0.000312	CcSEcCtD
Dolasetron—Hypotension—Lisinopril—coronary artery disease	8.6e-05	0.000311	CcSEcCtD
Dolasetron—Dizziness—Captopril—coronary artery disease	8.59e-05	0.000311	CcSEcCtD
Dolasetron—Rash—Trandolapril—coronary artery disease	8.58e-05	0.00031	CcSEcCtD
Dolasetron—Dermatitis—Trandolapril—coronary artery disease	8.57e-05	0.00031	CcSEcCtD
Dolasetron—Fatigue—Timolol—coronary artery disease	8.55e-05	0.00031	CcSEcCtD
Dolasetron—Rash—Enalapril—coronary artery disease	8.54e-05	0.000309	CcSEcCtD
Dolasetron—Dermatitis—Enalapril—coronary artery disease	8.53e-05	0.000309	CcSEcCtD
Dolasetron—Headache—Trandolapril—coronary artery disease	8.52e-05	0.000309	CcSEcCtD
Dolasetron—Asthenia—Losartan—coronary artery disease	8.49e-05	0.000307	CcSEcCtD
Dolasetron—Headache—Enalapril—coronary artery disease	8.49e-05	0.000307	CcSEcCtD
Dolasetron—Pain—Timolol—coronary artery disease	8.48e-05	0.000307	CcSEcCtD
Dolasetron—Rash—Telmisartan—coronary artery disease	8.43e-05	0.000305	CcSEcCtD
Dolasetron—Dermatitis—Telmisartan—coronary artery disease	8.42e-05	0.000305	CcSEcCtD
Dolasetron—Diarrhoea—Furosemide—coronary artery disease	8.39e-05	0.000304	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Lisinopril—coronary artery disease	8.38e-05	0.000304	CcSEcCtD
Dolasetron—Pruritus—Losartan—coronary artery disease	8.37e-05	0.000303	CcSEcCtD
Dolasetron—Headache—Telmisartan—coronary artery disease	8.37e-05	0.000303	CcSEcCtD
Dolasetron—Feeling abnormal—Ramipril—coronary artery disease	8.36e-05	0.000303	CcSEcCtD
Dolasetron—Dizziness—Perindopril—coronary artery disease	8.34e-05	0.000302	CcSEcCtD
Dolasetron—Gastrointestinal pain—Ramipril—coronary artery disease	8.3e-05	0.0003	CcSEcCtD
Dolasetron—Paraesthesia—Lisinopril—coronary artery disease	8.26e-05	0.000299	CcSEcCtD
Dolasetron—Dyspnoea—Lisinopril—coronary artery disease	8.2e-05	0.000297	CcSEcCtD
Dolasetron—Rash—Captopril—coronary artery disease	8.19e-05	0.000297	CcSEcCtD
Dolasetron—Dermatitis—Captopril—coronary artery disease	8.19e-05	0.000296	CcSEcCtD
Dolasetron—Somnolence—Lisinopril—coronary artery disease	8.18e-05	0.000296	CcSEcCtD
Dolasetron—Feeling abnormal—Timolol—coronary artery disease	8.17e-05	0.000296	CcSEcCtD
Dolasetron—Headache—Captopril—coronary artery disease	8.14e-05	0.000295	CcSEcCtD
Dolasetron—Gastrointestinal pain—Timolol—coronary artery disease	8.11e-05	0.000294	CcSEcCtD
Dolasetron—Dizziness—Furosemide—coronary artery disease	8.11e-05	0.000294	CcSEcCtD
Dolasetron—Dyspepsia—Lisinopril—coronary artery disease	8.1e-05	0.000293	CcSEcCtD
Dolasetron—Diarrhoea—Losartan—coronary artery disease	8.1e-05	0.000293	CcSEcCtD
Dolasetron—Urticaria—Ramipril—coronary artery disease	8.06e-05	0.000292	CcSEcCtD
Dolasetron—Abdominal pain—Ramipril—coronary artery disease	8.02e-05	0.00029	CcSEcCtD
Dolasetron—Body temperature increased—Ramipril—coronary artery disease	8.02e-05	0.00029	CcSEcCtD
Dolasetron—Decreased appetite—Lisinopril—coronary artery disease	8e-05	0.00029	CcSEcCtD
Dolasetron—Rash—Perindopril—coronary artery disease	7.96e-05	0.000288	CcSEcCtD
Dolasetron—Dermatitis—Perindopril—coronary artery disease	7.95e-05	0.000288	CcSEcCtD
Dolasetron—Fatigue—Lisinopril—coronary artery disease	7.93e-05	0.000287	CcSEcCtD
Dolasetron—Headache—Perindopril—coronary artery disease	7.9e-05	0.000286	CcSEcCtD
Dolasetron—Urticaria—Timolol—coronary artery disease	7.88e-05	0.000285	CcSEcCtD
Dolasetron—Pain—Lisinopril—coronary artery disease	7.87e-05	0.000285	CcSEcCtD
Dolasetron—Constipation—Lisinopril—coronary artery disease	7.87e-05	0.000285	CcSEcCtD
Dolasetron—Body temperature increased—Timolol—coronary artery disease	7.84e-05	0.000284	CcSEcCtD
Dolasetron—Abdominal pain—Timolol—coronary artery disease	7.84e-05	0.000284	CcSEcCtD
Dolasetron—Dizziness—Losartan—coronary artery disease	7.83e-05	0.000283	CcSEcCtD
Dolasetron—Rash—Furosemide—coronary artery disease	7.73e-05	0.00028	CcSEcCtD
Dolasetron—Dermatitis—Furosemide—coronary artery disease	7.73e-05	0.00028	CcSEcCtD
Dolasetron—Headache—Furosemide—coronary artery disease	7.68e-05	0.000278	CcSEcCtD
Dolasetron—Feeling abnormal—Lisinopril—coronary artery disease	7.58e-05	0.000275	CcSEcCtD
Dolasetron—Gastrointestinal pain—Lisinopril—coronary artery disease	7.53e-05	0.000272	CcSEcCtD
Dolasetron—Hypersensitivity—Ramipril—coronary artery disease	7.48e-05	0.000271	CcSEcCtD
Dolasetron—Rash—Losartan—coronary artery disease	7.46e-05	0.00027	CcSEcCtD
Dolasetron—Dermatitis—Losartan—coronary artery disease	7.45e-05	0.00027	CcSEcCtD
Dolasetron—Headache—Losartan—coronary artery disease	7.41e-05	0.000268	CcSEcCtD
Dolasetron—Urticaria—Lisinopril—coronary artery disease	7.31e-05	0.000265	CcSEcCtD
Dolasetron—Hypersensitivity—Timolol—coronary artery disease	7.31e-05	0.000265	CcSEcCtD
Dolasetron—Asthenia—Ramipril—coronary artery disease	7.28e-05	0.000264	CcSEcCtD
Dolasetron—Abdominal pain—Lisinopril—coronary artery disease	7.27e-05	0.000263	CcSEcCtD
Dolasetron—Body temperature increased—Lisinopril—coronary artery disease	7.27e-05	0.000263	CcSEcCtD
Dolasetron—Pruritus—Ramipril—coronary artery disease	7.18e-05	0.00026	CcSEcCtD
Dolasetron—Asthenia—Timolol—coronary artery disease	7.12e-05	0.000258	CcSEcCtD
Dolasetron—Pruritus—Timolol—coronary artery disease	7.02e-05	0.000254	CcSEcCtD
Dolasetron—Diarrhoea—Ramipril—coronary artery disease	6.94e-05	0.000251	CcSEcCtD
Dolasetron—Diarrhoea—Timolol—coronary artery disease	6.79e-05	0.000246	CcSEcCtD
Dolasetron—Hypersensitivity—Lisinopril—coronary artery disease	6.78e-05	0.000245	CcSEcCtD
Dolasetron—Dizziness—Ramipril—coronary artery disease	6.71e-05	0.000243	CcSEcCtD
Dolasetron—Asthenia—Lisinopril—coronary artery disease	6.6e-05	0.000239	CcSEcCtD
Dolasetron—Dizziness—Timolol—coronary artery disease	6.56e-05	0.000237	CcSEcCtD
Dolasetron—Pruritus—Lisinopril—coronary artery disease	6.51e-05	0.000236	CcSEcCtD
Dolasetron—Rash—Ramipril—coronary artery disease	6.4e-05	0.000232	CcSEcCtD
Dolasetron—Dermatitis—Ramipril—coronary artery disease	6.39e-05	0.000231	CcSEcCtD
Dolasetron—Headache—Ramipril—coronary artery disease	6.36e-05	0.00023	CcSEcCtD
Dolasetron—Diarrhoea—Lisinopril—coronary artery disease	6.3e-05	0.000228	CcSEcCtD
Dolasetron—Rash—Timolol—coronary artery disease	6.25e-05	0.000226	CcSEcCtD
Dolasetron—Dermatitis—Timolol—coronary artery disease	6.25e-05	0.000226	CcSEcCtD
Dolasetron—Headache—Timolol—coronary artery disease	6.21e-05	0.000225	CcSEcCtD
Dolasetron—Dizziness—Lisinopril—coronary artery disease	6.09e-05	0.00022	CcSEcCtD
Dolasetron—Rash—Lisinopril—coronary artery disease	5.8e-05	0.00021	CcSEcCtD
Dolasetron—Dermatitis—Lisinopril—coronary artery disease	5.8e-05	0.00021	CcSEcCtD
Dolasetron—Headache—Lisinopril—coronary artery disease	5.77e-05	0.000209	CcSEcCtD
Dolasetron—CYP2D6—Metabolism—HK2—coronary artery disease	1.34e-05	0.000382	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—AKR1B1—coronary artery disease	1.34e-05	0.000382	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—AKR1B1—coronary artery disease	1.33e-05	0.000379	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—HK2—coronary artery disease	1.33e-05	0.000379	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—SLC27A1—coronary artery disease	1.28e-05	0.000367	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—SLC27A1—coronary artery disease	1.27e-05	0.000363	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—LCAT—coronary artery disease	1.26e-05	0.00036	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CPT1B—coronary artery disease	1.26e-05	0.00036	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—LCAT—coronary artery disease	1.25e-05	0.000356	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CPT1B—coronary artery disease	1.25e-05	0.000356	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—APOA4—coronary artery disease	1.24e-05	0.000353	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—APOA4—coronary artery disease	1.23e-05	0.00035	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GK—coronary artery disease	1.21e-05	0.000346	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—HMGCS2—coronary artery disease	1.21e-05	0.000346	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PFKM—coronary artery disease	1.21e-05	0.000346	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GYG1—coronary artery disease	1.21e-05	0.000346	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—LDHA—coronary artery disease	1.21e-05	0.000346	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GATM—coronary artery disease	1.21e-05	0.000346	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	1.2e-05	0.000344	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PDHA1—coronary artery disease	1.19e-05	0.000341	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GCLM—coronary artery disease	1.19e-05	0.000341	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PDHA1—coronary artery disease	1.18e-05	0.000338	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GCLM—coronary artery disease	1.18e-05	0.000338	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—TXNRD1—coronary artery disease	1.16e-05	0.00033	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CYP11B2—coronary artery disease	1.16e-05	0.00033	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GCH1—coronary artery disease	1.16e-05	0.00033	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—AK1—coronary artery disease	1.16e-05	0.00033	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	1.15e-05	0.000328	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYP11B2—coronary artery disease	1.15e-05	0.000327	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—TXNRD1—coronary artery disease	1.15e-05	0.000327	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—SLC22A3—coronary artery disease	1.14e-05	0.000325	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—SLC22A3—coronary artery disease	1.13e-05	0.000322	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—HADH—coronary artery disease	1.12e-05	0.00032	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ARNTL—coronary artery disease	1.12e-05	0.00032	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ARNTL—coronary artery disease	1.11e-05	0.000318	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—HADH—coronary artery disease	1.11e-05	0.000318	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PLCD1—coronary artery disease	1.11e-05	0.000316	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PPAT—coronary artery disease	1.11e-05	0.000316	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—MDH2—coronary artery disease	1.11e-05	0.000316	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—UGCG—coronary artery disease	1.11e-05	0.000316	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	1.1e-05	0.000313	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	1.07e-05	0.000305	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PGM1—coronary artery disease	1.07e-05	0.000304	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—APOA2—coronary artery disease	1.06e-05	0.000304	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GPX2—coronary artery disease	1.06e-05	0.000304	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PLA2G2A—coronary artery disease	1.06e-05	0.000304	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PLA2G2A—coronary artery disease	1.05e-05	0.000301	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—APOA2—coronary artery disease	1.05e-05	0.000301	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GPX2—coronary artery disease	1.05e-05	0.000301	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ABCG5—coronary artery disease	1.05e-05	0.0003	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—SULT1A1—coronary artery disease	1.05e-05	0.0003	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—HK1—coronary artery disease	1.05e-05	0.0003	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GPX4—coronary artery disease	1.05e-05	0.0003	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—HK1—coronary artery disease	1.04e-05	0.000297	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—SULT1A1—coronary artery disease	1.04e-05	0.000297	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ABCG5—coronary artery disease	1.04e-05	0.000297	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GPX4—coronary artery disease	1.04e-05	0.000297	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	1.04e-05	0.000297	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—HADHA—coronary artery disease	1.04e-05	0.000297	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CKB—coronary artery disease	1.03e-05	0.000294	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PYGB—coronary artery disease	1.03e-05	0.000294	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—HADHA—coronary artery disease	1.03e-05	0.000294	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GSTA1—coronary artery disease	1.03e-05	0.000293	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GSTA1—coronary artery disease	1.02e-05	0.000291	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—LPA—coronary artery disease	1.02e-05	0.00029	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—LPA—coronary artery disease	1.01e-05	0.000287	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PLCB3—coronary artery disease	9.83e-06	0.000281	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PLCB3—coronary artery disease	9.75e-06	0.000278	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—APOA5—coronary artery disease	9.73e-06	0.000278	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PFKFB3—coronary artery disease	9.68e-06	0.000276	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—DLAT—coronary artery disease	9.68e-06	0.000276	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PLIN1—coronary artery disease	9.68e-06	0.000276	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—COX5B—coronary artery disease	9.68e-06	0.000276	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GSTM2—coronary artery disease	9.68e-06	0.000276	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—APOA5—coronary artery disease	9.65e-06	0.000275	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—P4HB—coronary artery disease	9.54e-06	0.000272	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—P4HB—coronary artery disease	9.46e-06	0.00027	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	9.37e-06	0.000268	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PLA2G1B—coronary artery disease	9.37e-06	0.000267	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PLA2G1B—coronary artery disease	9.29e-06	0.000265	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	9.18e-06	0.000262	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—SULT1E1—coronary artery disease	9.18e-06	0.000262	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	9.08e-06	0.000259	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—VCAN—coronary artery disease	8.83e-06	0.000252	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ALDOA—coronary artery disease	8.76e-06	0.00025	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—AKR1B1—coronary artery disease	8.76e-06	0.00025	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—HK2—coronary artery disease	8.76e-06	0.00025	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—VCAN—coronary artery disease	8.76e-06	0.00025	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ALDOA—coronary artery disease	8.69e-06	0.000248	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—DCN—coronary artery disease	8.51e-06	0.000243	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—DCN—coronary artery disease	8.43e-06	0.000241	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—SLC27A1—coronary artery disease	8.4e-06	0.00024	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ALDH2—coronary artery disease	8.28e-06	0.000236	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CPT1B—coronary artery disease	8.23e-06	0.000235	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—LCAT—coronary artery disease	8.23e-06	0.000235	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ALDH2—coronary artery disease	8.2e-06	0.000234	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—APOA4—coronary artery disease	8.08e-06	0.000231	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CYP2C19—coronary artery disease	8.06e-06	0.00023	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—LIPC—coronary artery disease	8.06e-06	0.00023	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—HBA1—coronary artery disease	8.06e-06	0.00023	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	8.06e-06	0.00023	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—APOC3—coronary artery disease	8.01e-06	0.000229	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	8e-06	0.000228	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—HBA1—coronary artery disease	7.99e-06	0.000228	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—LIPC—coronary artery disease	7.99e-06	0.000228	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	7.99e-06	0.000228	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYP2C19—coronary artery disease	7.99e-06	0.000228	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—LDLR—coronary artery disease	7.97e-06	0.000227	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—APOC3—coronary artery disease	7.95e-06	0.000227	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—LDLR—coronary artery disease	7.9e-06	0.000225	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	7.89e-06	0.000225	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—SLC9A1—coronary artery disease	7.87e-06	0.000225	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GSTT1—coronary artery disease	7.87e-06	0.000225	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PDHA1—coronary artery disease	7.81e-06	0.000223	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GCLM—coronary artery disease	7.81e-06	0.000223	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—SLC9A1—coronary artery disease	7.8e-06	0.000223	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GSTT1—coronary artery disease	7.8e-06	0.000223	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GCLC—coronary artery disease	7.78e-06	0.000222	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CETP—coronary artery disease	7.78e-06	0.000222	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GCLC—coronary artery disease	7.71e-06	0.00022	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CETP—coronary artery disease	7.71e-06	0.00022	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—SDC1—coronary artery disease	7.69e-06	0.00022	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—SDC1—coronary artery disease	7.63e-06	0.000218	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—TXNRD1—coronary artery disease	7.56e-06	0.000216	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CYP11B2—coronary artery disease	7.56e-06	0.000216	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—SLC22A3—coronary artery disease	7.45e-06	0.000213	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—HADH—coronary artery disease	7.34e-06	0.00021	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ARNTL—coronary artery disease	7.34e-06	0.00021	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PSMA6—coronary artery disease	7.27e-06	0.000207	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PSMB5—coronary artery disease	7.27e-06	0.000207	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PSMA6—coronary artery disease	7.21e-06	0.000206	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PSMB5—coronary artery disease	7.21e-06	0.000206	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	7.19e-06	0.000205	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CTGF—coronary artery disease	7.1e-06	0.000203	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CTGF—coronary artery disease	7.04e-06	0.000201	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GOT2—coronary artery disease	7.04e-06	0.000201	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—HMGCR—coronary artery disease	7.04e-06	0.000201	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—HMGCR—coronary artery disease	6.98e-06	0.000199	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GOT2—coronary artery disease	6.98e-06	0.000199	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	6.96e-06	0.000199	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—APOA2—coronary artery disease	6.96e-06	0.000199	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GPX2—coronary artery disease	6.96e-06	0.000199	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ABCG5—coronary artery disease	6.87e-06	0.000196	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GPX4—coronary artery disease	6.87e-06	0.000196	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—HK1—coronary artery disease	6.87e-06	0.000196	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—SULT1A1—coronary artery disease	6.87e-06	0.000196	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—HADHA—coronary artery disease	6.79e-06	0.000194	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GSTA1—coronary artery disease	6.71e-06	0.000192	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—LPA—coronary artery disease	6.64e-06	0.000189	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PLCB1—coronary artery disease	6.47e-06	0.000185	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PLCB3—coronary artery disease	6.43e-06	0.000184	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PLCB1—coronary artery disease	6.41e-06	0.000183	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—APOA5—coronary artery disease	6.36e-06	0.000182	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	6.29e-06	0.00018	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ABCA1—coronary artery disease	6.27e-06	0.000179	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—P4HB—coronary artery disease	6.24e-06	0.000178	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ABCA1—coronary artery disease	6.22e-06	0.000178	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	6.13e-06	0.000175	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GGT1—coronary artery disease	6.07e-06	0.000173	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GOT1—coronary artery disease	6.07e-06	0.000173	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GOT1—coronary artery disease	6.02e-06	0.000172	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GGT1—coronary artery disease	6.02e-06	0.000172	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—VCAN—coronary artery disease	5.77e-06	0.000165	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ALDOA—coronary artery disease	5.73e-06	0.000164	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—DCN—coronary artery disease	5.56e-06	0.000159	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GSTP1—coronary artery disease	5.46e-06	0.000156	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ALDH2—coronary artery disease	5.41e-06	0.000154	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GSTP1—coronary artery disease	5.41e-06	0.000154	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	5.41e-06	0.000154	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—HMOX1—coronary artery disease	5.38e-06	0.000154	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	5.36e-06	0.000153	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—HMOX1—coronary artery disease	5.33e-06	0.000152	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CAT—coronary artery disease	5.31e-06	0.000152	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—HBA1—coronary artery disease	5.27e-06	0.000151	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CYP2C19—coronary artery disease	5.27e-06	0.000151	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—LIPC—coronary artery disease	5.27e-06	0.000151	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	5.27e-06	0.000151	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CAT—coronary artery disease	5.26e-06	0.00015	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—APOC3—coronary artery disease	5.24e-06	0.00015	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—LDLR—coronary artery disease	5.21e-06	0.000149	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—APOB—coronary artery disease	5.15e-06	0.000147	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GSTT1—coronary artery disease	5.15e-06	0.000147	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—SLC9A1—coronary artery disease	5.15e-06	0.000147	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—APOB—coronary artery disease	5.11e-06	0.000146	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GCLC—coronary artery disease	5.09e-06	0.000145	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CETP—coronary artery disease	5.09e-06	0.000145	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—SDC1—coronary artery disease	5.03e-06	0.000144	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GSTM1—coronary artery disease	5.01e-06	0.000143	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GSTM1—coronary artery disease	4.97e-06	0.000142	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—LPL—coronary artery disease	4.92e-06	0.000141	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—LPL—coronary artery disease	4.88e-06	0.000139	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GPX1—coronary artery disease	4.8e-06	0.000137	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GPX1—coronary artery disease	4.76e-06	0.000136	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PSMA6—coronary artery disease	4.75e-06	0.000136	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PSMB5—coronary artery disease	4.75e-06	0.000136	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CD36—coronary artery disease	4.68e-06	0.000133	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CTGF—coronary artery disease	4.64e-06	0.000133	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CD36—coronary artery disease	4.64e-06	0.000132	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PPP2CA—coronary artery disease	4.62e-06	0.000132	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—HMGCR—coronary artery disease	4.6e-06	0.000131	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GOT2—coronary artery disease	4.6e-06	0.000131	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PPP2CA—coronary artery disease	4.58e-06	0.000131	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—MTHFR—coronary artery disease	4.43e-06	0.000127	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—MTHFR—coronary artery disease	4.39e-06	0.000125	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PLCB1—coronary artery disease	4.23e-06	0.000121	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—AGT—coronary artery disease	4.21e-06	0.00012	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—AGT—coronary artery disease	4.17e-06	0.000119	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—APOE—coronary artery disease	4.13e-06	0.000118	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ABCA1—coronary artery disease	4.1e-06	0.000117	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—APOE—coronary artery disease	4.09e-06	0.000117	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—APOA1—coronary artery disease	4.08e-06	0.000116	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—APOA1—coronary artery disease	4.04e-06	0.000115	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GOT1—coronary artery disease	3.97e-06	0.000113	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GGT1—coronary artery disease	3.97e-06	0.000113	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.87e-06	0.000111	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PPARG—coronary artery disease	3.59e-06	0.000103	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GSTP1—coronary artery disease	3.57e-06	0.000102	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PPARG—coronary artery disease	3.56e-06	0.000102	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—POMC—coronary artery disease	3.54e-06	0.000101	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	3.53e-06	0.000101	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—HMOX1—coronary artery disease	3.52e-06	0.0001	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—POMC—coronary artery disease	3.51e-06	0.0001	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CAT—coronary artery disease	3.47e-06	9.91e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—APOB—coronary artery disease	3.37e-06	9.62e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GSTM1—coronary artery disease	3.28e-06	9.36e-05	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ALB—coronary artery disease	3.23e-06	9.22e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—LPL—coronary artery disease	3.22e-06	9.19e-05	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ALB—coronary artery disease	3.2e-06	9.14e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GPX1—coronary artery disease	3.14e-06	8.96e-05	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—NOS3—coronary artery disease	3.09e-06	8.82e-05	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—NOS3—coronary artery disease	3.06e-06	8.75e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CD36—coronary artery disease	3.06e-06	8.73e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PPP2CA—coronary artery disease	3.02e-06	8.62e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—MTHFR—coronary artery disease	2.9e-06	8.27e-05	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PTGS2—coronary artery disease	2.83e-06	8.07e-05	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PTGS2—coronary artery disease	2.8e-06	8e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—AGT—coronary artery disease	2.75e-06	7.86e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—APOE—coronary artery disease	2.7e-06	7.7e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—APOA1—coronary artery disease	2.67e-06	7.61e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PPARG—coronary artery disease	2.35e-06	6.71e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—POMC—coronary artery disease	2.32e-06	6.61e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ALB—coronary artery disease	2.11e-06	6.03e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—NOS3—coronary artery disease	2.02e-06	5.77e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.85e-06	5.28e-05	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PIK3CA—coronary artery disease	1.74e-06	4.96e-05	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PIK3CA—coronary artery disease	1.72e-06	4.92e-05	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—AKT1—coronary artery disease	1.42e-06	4.06e-05	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—AKT1—coronary artery disease	1.41e-06	4.02e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.14e-06	3.25e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—AKT1—coronary artery disease	9.29e-07	2.65e-05	CbGpPWpGaD
